This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
For the first time, researchers looked at the pancreatic enzyme replacement therapy (PERT) dose needed to achieve therapeutic goals in patients with EPI according to the underlying cause.
Medscape Medical News